Early recovery of the platelet count after decitabine-based induction chemotherapy is a prognostic marker of superior response in elderly patients with newly diagnosed acute myeloid leukaemia

Early recovery of the platelet count after decitabine-based induction chemotherapy is a prognostic marker of superior response in elderly patients with newly diagnosed acute myeloid leukaemia

Abstract Background Definite prognostic clinical factors of benefit for decitabine-based induction chemotherapy in elderly patients newly diagnosed with acute myeloid leukaemia (AML) are not identified. This study was designed to explore the potential biomarker, especially regeneration of haematopoi...

Full description

Bibliographic Details
Main Authors: Jiayu Huang, Huihui Zhao, Ming Hong, Han Zhu, Yu Zhu, Yun Lian, Shan Li, Jianyong Li, Sixuan Qian
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Cancer
Subjects:
Platelet recovery
Prognostic indicator
Decitabine
Acute myeloid leukaemia
Elderly
Online Access:http://link.springer.com/article/10.1186/s12885-018-5160-5

Internet

http://link.springer.com/article/10.1186/s12885-018-5160-5

Similar Items